|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 38/10 | (2013.01) | ||
| A61P 15/10 | (2006.01) | ||
| A61K 38/1716 | (2013.01) | ||
| A61P 15/10 | (2018.01) |
| (11) | Patento numeris | 3576772 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18707189.9 |
| Europos patento paraiškos padavimo data | 2018-02-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-12-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/017349 |
| Data | 2018-02-08 |
| (87) | Numeris | WO 2018/160335 |
| Data | 2018-09-07 |
| (30) | Numeris | Data | Šalis |
| 201715446406 | 2017-03-01 | US |
| (72) |
AVERBACK, Paul , BS
|
| (73) |
Nymox Corporation ,
777 Terrace Avenue, Hasbrouck Heights, NJ 07604,
US
|
| (54) | FEXAPOTID FOR IMPROVING SEXUAL FUNCTION |
| FEXAPOTID FOR IMPROVING SEXUAL FUNCTION |